265 related articles for article (PubMed ID: 32002590)
21. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
Yadav M; Zhang J; Fischer H; Huang W; Lutay N; Cirl C; Lum J; Miethke T; Svanborg C
PLoS Pathog; 2010 Sep; 6(9):e1001120. PubMed ID: 20886104
[TBL] [Abstract][Full Text] [Related]
22. A bioinformatic approach to the identification of bacterial proteins interacting with Toll-interleukin 1 receptor-resistance (TIR) homology domains.
Turner JD
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):13-21. PubMed ID: 12770755
[TBL] [Abstract][Full Text] [Related]
23. Binding specificity of Toll-like receptor cytoplasmic domains.
Brown V; Brown RA; Ozinsky A; Hesselberth JR; Fields S
Eur J Immunol; 2006 Mar; 36(3):742-53. PubMed ID: 16482509
[TBL] [Abstract][Full Text] [Related]
24. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
25. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.
Loiarro M; Sette C; Gallo G; Ciacci A; Fantò N; Mastroianni D; Carminati P; Ruggiero V
J Biol Chem; 2005 Apr; 280(16):15809-14. PubMed ID: 15755740
[TBL] [Abstract][Full Text] [Related]
26. Blocking TIR Domain Interactions in TLR9 Signaling.
Javmen A; Szmacinski H; Lakowicz JR; Toshchakov VY
J Immunol; 2018 Aug; 201(3):995-1006. PubMed ID: 29914886
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
[TBL] [Abstract][Full Text] [Related]
28. Molecular interactions in interleukin and toll-like receptor signaling pathways.
Snyder GA; Sundberg EJ
Curr Pharm Des; 2014; 20(8):1244-58. PubMed ID: 23713776
[TBL] [Abstract][Full Text] [Related]
29. TIR domain-containing adaptors define the specificity of TLR signaling.
Yamamoto M; Takeda K; Akira S
Mol Immunol; 2004 Feb; 40(12):861-8. PubMed ID: 14698224
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88.
Nishiya T; Kajita E; Horinouchi T; Nishimoto A; Miwa S
FEBS Lett; 2007 Jul; 581(17):3223-9. PubMed ID: 17583698
[TBL] [Abstract][Full Text] [Related]
31. Characterization of bbtTICAM from amphioxus suggests the emergence of a MyD88-independent pathway in basal chordates.
Yang M; Yuan S; Huang S; Li J; Xu L; Huang H; Tao X; Peng J; Xu A
Cell Res; 2011 Oct; 21(10):1410-23. PubMed ID: 21931360
[TBL] [Abstract][Full Text] [Related]
32. Gene structure, cDNA characterization and RNAi-based functional analysis of a myeloid differentiation factor 88 homolog in Tenebrio molitor larvae exposed to Staphylococcus aureus infection.
Patnaik BB; Patnaik HH; Seo GW; Jo YH; Lee YS; Lee BL; Han YS
Dev Comp Immunol; 2014 Oct; 46(2):208-21. PubMed ID: 24755285
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
34. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
Qin J; Qian Y; Yao J; Grace C; Li X
J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
[TBL] [Abstract][Full Text] [Related]
35. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
36. Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways.
Narayanan KB; Park HH
Apoptosis; 2015 Feb; 20(2):196-209. PubMed ID: 25563856
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.
Khan JA; Brint EK; O'Neill LA; Tong L
J Biol Chem; 2004 Jul; 279(30):31664-70. PubMed ID: 15123616
[TBL] [Abstract][Full Text] [Related]
38. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
39. Phylogeny of Toll-like receptor signaling: adapting the innate response.
Roach JM; Racioppi L; Jones CD; Masci AM
PLoS One; 2013; 8(1):e54156. PubMed ID: 23326591
[TBL] [Abstract][Full Text] [Related]
40. The STIR-domain superfamily in signal transduction, development and immunity.
Novatchkova M; Leibbrandt A; Werzowa J; Neubüser A; Eisenhaber F
Trends Biochem Sci; 2003 May; 28(5):226-9. PubMed ID: 12765832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
